Novo Nordisk just cut the price of its weight loss drug by more than half. But there's a catch
Following in the steps of its rival Eli Lilly (LLY), Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half for patients that pay without insurance.Read more...
Following in the steps of its rival Eli Lilly (LLY), Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half for patients that pay without insurance.
